Shanghai-Based ProGenTech Draws $21m in VC Funds
Filed in archive Venture Capital by Greg Cruey on April 02, 2008
According to East Bay Business Times the two funding sources were Bay City Capital of San Francisco and DT Capital of Shanghai.
A press release said that ProGenTech makes "a contamination free, cassette based automated nucleic acid
purification systems." I'd probably have to see a picture and take a few biochemistry classes to be able to explain exactly what that means. But the funding is part of a growing trend of venture capital involvement in the medical technologies industry in China.ProGenTech has been around since 2005 and has about 40 employees.

Permalink: Shanghai-Based ProGenTech Draws $21m in VC Funds
Tags:
ProGenTech Venture capital china venture venture+capital draws+funds based+progentech
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/118961












